학술논문
The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation.
Document Type
Article
Author
Source
Subject
*NON-small-cell lung carcinoma
*LUNG cancer
*OVERALL survival
*CANCER diagnosis
*
*
*
Language
ISSN
1661-6596
Abstract
The severe prognosis linked with a lung cancer diagnosis has changed with the discovery of oncogenic molecularly driven subgroups and the use of tailored treatment. ALK-translocated advanced lung cancer is the most interesting model, having achieved the longest overall survival. Here, we report the most important paradigmatic shifts in the prognosis and treatment for this subgroup population occurred among lung cancer. [ABSTRACT FROM AUTHOR]